polyribosyl ribitol phosphate
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT00127855)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polyribosyl ribitol phosphate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05775848 | Phase 3 | May 31, 2023 | ML Bio Solutions, Inc. |
| NCT04800874 | Phase 2 | Feb 18, 2021 | ML Bio Solutions, Inc., Virginia Commonwealth University |
| NCT00127855 | Phase 2 | Mar 1, 2003 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ML Bio Solutions, Inc. | For profit | 2 | 2 | 2 | 2021 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2003 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1